Form 4 for LIF Life360, Inc.
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-16 · accession 0000905148-25-004433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-18 | 2025-12-16 | LIF | Hulls Chris | Dir | S - Sale | $63.96 | -1,846 | 0 | -100% | -$118.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | S | D | 1,139 | $63.63 | 707 | I Held by ICCA Labs, LLC | — | — | (F1) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. (F2) The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |
| 2 | Common | Common Stock | 2025-12-16 | S | D | 707 | $64.49 | 0 | I Held by ICCA Labs, LLC | — | — | (F3) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. (F2) The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |